| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Eyepoint, Inc. (EYPT) have been net buyers, picking up 10,600 shares worth roughly $52K on balance.
EYPT sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 8.27M | $129.79M | - | |
| Dir | 294.3K | - | - | |
| CFO | 122.5K | - | - | |
| Dir | 49.1K | $242.1K | - | |
| CEO | 9.6K | $141.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 11, 2025 | Ribeiro Ramiro | Chief Medical Officer | Sell10b5-1 | 2,722 | $11.61 | $31,602.42 | -100% | +20.8% | - | |
| May 19, 2025 | Zaderej Karen L.80 | Director | Buy | 10,000 | $5.90 | $59,000.00 | +37.7% | +85.7% | +93.8% | |
| May 15, 2025 | Zaderej Karen L.80 | Director | Buy | 10,000 | $5.45 | $54,450.00 | +60.6% | +92.5% | +115.9% | |
| Aug 21, 2024 | Ando Goran | Director | Buy | 5,000 | $7.95 | $39,750.00 | +61.3% | +1.8% | +28.2% | |
| Aug 20, 2024 | Dicicco Wendy F | Director | Buy | 2,567 | $7.79 | $19,996.93 | +34.7% | +11.1% | +49.1% | |
| Aug 19, 2024 | Zaderej Karen L.80 | Director | Buy | 12,500 | $7.98 | $99,750.00 | +312.5% | +8.1% | +39.0% | |
| Aug 16, 2024 | Lurker Nancy77 | Director | Buy | 3,173 | $7.88 | $25,003.24 | +3.4% | +32.3% | +39.8% | |
| Jul 12, 2024 | Guyer David R62 | Director | Sale+OE10b5-1 | 11,625 | $10.06 | $116,995.16 | -86.3% | -20.2% | +0.3% | |
| Jun 3, 2024 | Guyer David R62 | Director | Sale+OE10b5-1 | 11,625 | $10.30 | $119,704.95 | -75.9% | -17.5% | -17.8% | |
| May 14, 2024 | Guyer David R62 | Director | Sale+OE10b5-1 | 11,625 | $12.65 | $147,044.63 | -67.7% | -32.9% | -55.9% |